Does ALPELISIB Cause Therapy non-responder? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapy non-responder have been filed in association with ALPELISIB (PIQRAY). This represents 0.2% of all adverse event reports for ALPELISIB.
13
Reports of Therapy non-responder with ALPELISIB
0.2%
of all ALPELISIB reports
2
Deaths
1
Hospitalizations
How Dangerous Is Therapy non-responder From ALPELISIB?
Of the 13 reports, 2 (15.4%) resulted in death, 1 (7.7%) required hospitalization.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPELISIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ALPELISIB Cause?
Hyperglycaemia (1,575)
Rash (1,393)
Diarrhoea (1,336)
Blood glucose increased (1,105)
Death (921)
Nausea (860)
Fatigue (817)
Decreased appetite (546)
Weight decreased (508)
Malignant neoplasm progression (497)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which ALPELISIB Alternatives Have Lower Therapy non-responder Risk?
ALPELISIB vs ALPHA.-LIPOIC ACID
ALPELISIB vs ALPHA.-TOCOPHEROL
ALPELISIB vs ALPHA.-TOCOPHEROL, D-
ALPELISIB vs ALPHA.-TOCOPHEROL, DL-
ALPELISIB vs ALPHA.1-PROTEINASE INHIBITOR HUMAN